Trinity’s Dr David Finlay, ONK’s Prof Michael O’Dwyer and  Enterprise Ireland’s Lawrence Lee: “In working with Dr Finlay, we are collaborating with the pioneering expert in the field of NK immunometabolism,” says Prof O’Dwyer. Photograph: Chris Bellew

ONK Therapeutics, a Galway company developing enhanced natural killer cells in the immune system to target cancers, is teaming up with Trinity College(...)